Santarus, Inc. (Nasdaq:SNTS)
Shares of SNTS soared after the company and Salix Pharmaceuticals, Ltd. reported that they have entered into a definitive merger agreement under which Salix will acquire all of the outstanding common stock of SNTS for $32.00 per share in cash (without interest).
The all-cash transaction values SNTS at approximately $2.6 billion.
SNTS also reported its financial results for the third quarter 2013, posting total revenues of $98.8 million, an 81% increase year over year, and net income of $30.3 million, or $0.38 diluted earnings per share, compared to $9.0 million, or $0.13 diluted earnings per share, in the same period the prior year.
SNTS is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by physician specialists.
More about Santarus, Inc. (Nasdaq:SNTS) at www.santarus.com
**
Crown Equity Holdings Inc. (CRWE)
More than half, 57%, of business buyers have purchased goods for their companies online, and 37% said they expect to spend a bigger proportion of their annual procurement budgets online next year, according to Acquity Group LLC’s 2013 State of B2B Procurement Study.
CRWE is refocusing its strategic plan for future growth and services with its original online business-to-business (B2B) marketplace platform for manufacturers and small to large businesses on a global basis to sell and acquire various types of merchandise, targeting the multi-billion dollar B2B Industry.
CRWE has updated its membership driven online e-commerce venture business plan. The name of the business will be known as “iB2B Global”. The company has been in contact with several high level IT companies in India to help support the project in the United States.
Together with its digital network of websites, CRWE offers advertising branding and marketing services as a worldwide online multi-media publisher. CRWE 's advertising services cover and connect a range of marketing specialties, as well as provide search engine optimization for clients interested in online media awareness. The company launches, invests and manages select businesses, projects and real estate endeavors.
More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com
**
Air Methods Corporation (Nasdaq:AIRM)
The price on AIRM stock surged after the company reported its financial results, reflecting a return to growth in earnings fueled by strong growth in net revenue per patient transport and more moderate maintenance expenditures as anticipated. AIRM also was upgraded from Buy to Strong Buy with a price target of $55 by brokerage firm Feltl & Co.
For the third quarter 2013, AIRM posted revenue of $252.4 million, a 14% increase year over year, and net income of $35.6 million, or $0.91 per diluted share, compared to $27.8 million, or $0.71 per diluted share, in the same period the prior year.
AIRM is the global leader in air medical transportation. The Air Medical Services Division is the largest provider of air medical transport services in the United States. The United Rotorcraft Division specializes in the design and manufacture of aeromedical and aerospace technology. The Tourism Division is comprised of Sundance Helicopters, Inc., which provides helicopter tours and charter flights, primarily focusing on Grand Canyon tours.
AIRM 's fleet of owned, leased or maintained aircraft features over 400 helicopters and fixed wing aircraft.
More about Air Methods Corporation (Nasdaq:AIRM) at www.airmethods.com
**
Read Full Disclaimer at www.drstockpick.com/disclaimer
